These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10773542

  • 1. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
    Bergmann R, Brust P, Scheunemann M, Pietzsch HJ, Seifert S, Roux F, Johannsen B.
    Nucl Med Biol; 2000 Feb; 27(2):135-41. PubMed ID: 10773542
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
    Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D.
    J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
    [Abstract] [Full Text] [Related]

  • 5. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
    Gomes CM, Abrunhosa AJ, Pauwels EK, Botelho MF.
    Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
    [Abstract] [Full Text] [Related]

  • 6. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
    Chen WS, Luker KE, Dahlheimer JL, Pica CM, Luker GD, Piwnica-Worms D.
    Biochem Pharmacol; 2000 Aug 01; 60(3):413-26. PubMed ID: 10856437
    [Abstract] [Full Text] [Related]

  • 7. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I, Gülbaş Z, Ocak S, Kaya E, Alataş F, Vardareli E, Metintaş M.
    J Comput Assist Tomogr; 2007 Aug 01; 31(5):795-9. PubMed ID: 17895794
    [Abstract] [Full Text] [Related]

  • 8. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K, Kawano H, Moriyama T, Uehara H, Sameshima T, Oku T, Goya T, Wakisaka S, Nagamachi S, Jinnouchi S, Tamura S.
    Eur J Nucl Med; 1998 Apr 01; 25(4):401-9. PubMed ID: 9553170
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
    Zhou J, Higashi K, Ueda Y, Kodama Y, Guo D, Jisaki F, Sakurai A, Takegami T, Katsuda S, Yamamoto I.
    J Nucl Med; 2001 Oct 01; 42(10):1476-83. PubMed ID: 11585860
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
    Mubashar M, Harrington KJ, Chaudhary KS, Lalani el-N, Stamp GW, Peters AM.
    Acta Oncol; 2004 Oct 01; 43(5):443-52. PubMed ID: 15360048
    [Abstract] [Full Text] [Related]

  • 14. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
    Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, Fojo T, Chen CC.
    Clin Cancer Res; 2003 Feb 01; 9(2):650-6. PubMed ID: 12576431
    [Abstract] [Full Text] [Related]

  • 15. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD, Rao VV, Crankshaw CL, Dahlheimer J, Piwnica-Worms D.
    Biochemistry; 1997 Nov 18; 36(46):14218-27. PubMed ID: 9369495
    [Abstract] [Full Text] [Related]

  • 16. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
    Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM.
    Biochemistry; 1995 Sep 26; 34(38):12210-20. PubMed ID: 7547962
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L, Rieger J, Winter S, Streffer J, Esser P, Dichgans J, Meyermann R, Weller M.
    Acta Neuropathol; 2000 May 26; 99(5):555-62. PubMed ID: 10805101
    [Abstract] [Full Text] [Related]

  • 20. Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines.
    Perek N, Prevot N, Koumanov F, Frere D, Sabido O, Beauchesne P, Dubois F.
    Nucl Med Biol; 2000 Apr 26; 27(3):299-307. PubMed ID: 10832087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.